Levamlodipine

Drug Profile

Levamlodipine

Alternative Names: S-amlodipine

Latest Information Update: 11 Jul 2007

Price : $50

At a glance

  • Originator Sepracor
  • Class Antihypertensives; Dihydropyridines; Nicotinic-acids; Small molecules
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Angina pectoris; Hypertension

Most Recent Events

  • 02 Nov 2005 Levamlodipine is available for licensing in USA (http://www.sepracor.com)
  • 06 May 2002 Phase-II clinical trials in Hypertension in USA (unspecified route)
  • 29 Oct 1998 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top